Medical cannabis patients report improvements in anxiety, pain, and sleep
The outcomes of the first cohort of medical cannabis patients in the UK have demonstrated significant improvements in anxiety, pain, and sleep for medical...
Evidence, policy and regulation in medical cannabis
The Centre for Medicinal Cannabis hosted a crucial summit in April aimed at shaping the future of the UK’s medical cannabis sector.
On Thursday 15...
Medicinal cannabis research gets $1.5m for cancer treatment symptoms
A new University of Adelaide trial will explore the use of personalised medicinal cannabis dosing to prevent common and impactful symptoms of treatment in...
Access to medicinal cannabis treatments in Europe
In this article, Sita Schubert, General Secretary of the European Medicinal Cannabis Association, discusses the need to get better access to medicinal cannabis treatments...
Natural versus synthetic CBD
Richard O’Halloran, CEO of Biosportart, discusses natural versus synthetic cannabidiol (CBD) compounds for use in products and what this means for the CBD industry.
CBD...
Examining the future of Europe’s medical cannabis treatments
Sita Schubert, the General Secretary of the European Medicinal Cannabis Association, discusses the future of medical cannabis treatments in Europe, looking at how they...
UK policy oversight sees farmers waste millions of pounds worth of CBD
A new report co-ordinated by third sector drug policy reform organisation Volteface has today been released, promising a solution to ‘draconian, pointless’ hemp legislation.
The...
Groundbreaking paper sets out recommendations for UK cannabis industry
A groundbreaking paper has set out recommendations to facilitate a multibillion-pound UK medical cannabis industry that could create tens of thousands of jobs.
The paper...
Exploring the pharmacological and placebo effects of CBD for pain
A new study has shed light on the pain-reducing effects of CBD, as well as the impact that the placebo effect may have on...
Treating hypertension with cannabis
Ran Abuhasira of Ben-Gurion University of the Negev speaks to HEQ about the use of cannabis in treating elderly patients.
In February 2021, researchers at...
Investing in the future of the medical cannabis industry
Akerna CEO Jessica Billingsley speaks with MCN about the future of the medical cannabis industry, regarding technology, finance and cannabis policy.
Jessica Billingsley, who will...
XPhyto: Is mescaline the next big mood-modifying medicine?
Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Medical cannabis care in the era of personalised medicine
In the post-COVID-19 era, now more than ever, patients are critical of the healthcare they receive. Yaron Gissin, Chief Innovation Officer of the Sade...
Changing European hemp policy
Lorenza Romanese, Managing Director of the European Industrial Hemp Association, speaks with HEQ about the benefits of hemp and its derivatives and the need...
Impacts of recreational and medical cannabis legalisation in Canada
Dr Philippa Hawley tells Health Europa Quarterly about the effects of recreational legalisation on medical cannabis users
Following the broadly successful legalisation of cannabis for...
The benefits of cannabis for treating chronic pain
Dr Andrew Agius, Medical Director at the Pain Clinic, speaks to HEQ about the benefits of cannabis in treating chronic pain.
Cannabis has been used...
Greenheart CBD: the first company to introduce a CBD DeFi token
Greenheart offers premium seed-to-shelf CBD and an innovative decentralised finance token.
Greenheart CBD is an Irish-owned company with a vision to bring the finest Irish-made...
First medical cannabis clinic approved by Scottish regulator
Sapphire Medical Clinics is the first medical cannabis clinic to be approved by the Scottish regulator, Healthcare Improvement Scotland.
Sapphire Medical, which was the first...
Cannalean cannabis edibles for reducing cholesterol
Cannalean’s unique CBD formulation could help to treat dyslipidaemia, without the side effects of statins.
My 52-year-old husband is usually very healthy. He exercises daily,...
Medical cannabis ‘made in Denmark’
How Aurora Europe is ensuring reliable access to high-quality medical cannabis for Europe and beyond.
There is growing recognition in Europe and across the world...
